NasdaqGM - Delayed Quote USD

Astria Therapeutics, Inc. (ATXS)

4.2900
+0.0300
+(0.70%)
At close: 4:00:01 PM EDT
4.2900
0.00
(0.00%)
After hours: 4:38:30 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
124,403
111,558
67,831
53,503
30,359
Operating Income
-124,403
-111,558
-67,831
-53,503
-30,359
Net Non Operating Interest Income Expense
16,465
17,360
10,201
1,724
122
Other Income Expense
-103
-62
-15,261
-55
-164,675
Pretax Income
-108,041
-94,260
-72,891
-51,834
-194,912
Net Income Common Stockholders
-108,041
-94,260
-72,891
-51,834
-219,349
Diluted NI Available to Com Stockholders
-108,041
-94,260
-72,891
-51,834
-219,349
Basic EPS
-1.88
-1.68
-2.42
-3.55
-24.58
Diluted EPS
-1.88
-1.68
-2.42
-3.55
-24.58
Basic Average Shares
57,588.8860
56,161.2490
30,123.3160
14,620.6180
8,925.1730
Diluted Average Shares
57,588.8860
56,161.2490
30,123.3160
14,620.6180
8,925.1730
Total Operating Income as Reported
-124,403
-111,558
-83,030
-53,503
-194,976
Total Expenses
124,403
111,558
67,831
53,503
30,359
Net Income from Continuing & Discontinued Operation
-108,041
-94,260
-72,891
-51,834
-194,912
Normalized Income
-108,041
-94,260
-57,692
-51,834
-30,295
Interest Income
16,465
17,360
10,201
1,724
122
Net Interest Income
16,465
17,360
10,201
1,724
122
EBIT
-124,403
-111,558
-67,831
-53,503
-30,359
EBITDA
-124,403
-111,558
-67,831
-53,503
-30,359
Net Income from Continuing Operation Net Minority Interest
-108,041
-94,260
-72,891
-51,834
-194,912
Total Unusual Items Excluding Goodwill
0
0
-15,199
0
-164,617
Total Unusual Items
0
0
-15,199
0
-164,617
Normalized EBITDA
-124,403
-111,558
-52,632
-53,503
134,258
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/25/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers